chr11-2445096-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000218.3(KCNQ1):c.-3G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000462 in 1,082,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
KCNQ1
NM_000218.3 5_prime_UTR
NM_000218.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.222
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.-3G>A | 5_prime_UTR_variant | 1/16 | ENST00000155840.12 | NP_000209.2 | ||
KCNQ1 | NM_001406836.1 | c.-3G>A | 5_prime_UTR_variant | 1/15 | NP_001393765.1 | |||
KCNQ1 | NM_001406837.1 | c.-365G>A | 5_prime_UTR_variant | 1/17 | NP_001393766.1 | |||
KCNQ1 | NM_001406838.1 | c.-3G>A | 5_prime_UTR_variant | 1/11 | NP_001393767.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840 | c.-3G>A | 5_prime_UTR_variant | 1/16 | 1 | NM_000218.3 | ENSP00000155840.2 | |||
KCNQ1 | ENST00000646564 | c.-3G>A | 5_prime_UTR_variant | 1/11 | ENSP00000495806.2 | |||||
KCNQ1 | ENST00000496887.7 | c.24-287G>A | intron_variant | 5 | ENSP00000434560.2 |
Frequencies
GnomAD3 genomes AF: 0.0000203 AC: 3AN: 147896Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
147896
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000214 AC: 2AN: 934202Hom.: 0 Cov.: 30 AF XY: 0.00000228 AC XY: 1AN XY: 439316
GnomAD4 exome
AF:
AC:
2
AN:
934202
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
439316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000203 AC: 3AN: 147896Hom.: 0 Cov.: 32 AF XY: 0.0000139 AC XY: 1AN XY: 72038
GnomAD4 genome
AF:
AC:
3
AN:
147896
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
72038
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2022 | The c.-3G>A variant is located in the 5' untranslated region (5’ UTR) of the KCNQ1 gene. This variant results from a G to A substitution 3 nucleotides upstream from the first translated codon. Based on nucleotide sequence alignment, this position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at